GH Competitors & Alternatives
Compare Guardant Health Inc with similar stocks in the same industry
Diagnostics & Research
GH
Main Stock$118.95
Tradestie Score
59
Market Cap
$7.81B
Revenue Growth
0.5%
Analyst Upside
+9.7%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NTRA
Natera, Inc. Common Stock
|
$203.19
|
$22.18B | - | 62 | Compare |
|
DGX
Quest Diagnostics Inc.
|
$195.21
|
$20.36B | 21.4 | 65 | Compare |
|
WAT
Waters Corp
|
$342.37
|
$19.04B | 43.5 | 55 | Compare |
|
ILMN
Illumina Inc
|
$144.41
|
$15.72B | 25.8 | 58 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$432.80
|
$15.28B | 27.1 | 59 | Compare |
|
ICLR
Icon Plc
|
$116.78
|
$14.96B | 15.7 | 57 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$96.95
|
$10.65B | 45.9 | 53 | Compare |
|
QGEN
QIAGEN N.V.
|
$35.17
|
$10.04B | 17.8 | 59 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$160.30
|
$8.39B | - | 46 | Compare |
More GH Analysis
Data updated: May 24, 2026 | Industry: Diagnostics & Research (SIC 8071)
35 stocks in this industry